CASCADE Researchers Call For Open Discussions About EU Chemicals Legislation
Main Category: ConferencesArticle Date: 27 Mar 2006 - 11:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Scientists studying chemicals in food call for joint discussions with consumers and industry on the proposed EU chemicals legislation. At the Annual Meeting of the EU supported research Network CASCADE, March 28-31, in St Malo France, over 90 scientists from Europe, Japan and USA meet to discuss the latest scientific results in the field.
Currently, more than 100 000 chemicals are released into the environment and come in contact with humans via for example preservatives in food, flame retardants in computers and plastic softeners. For about 80 000 of these chemicals there is not enough knowledge to say if, and in that case how, harmful they might be to humans. Chemicals as contaminants in food are of great concern to European consumers, as shown in the latest EU Barometer survey1. It shows that 63% are concerned about pesticide residues in fruit and vegetables, as compared to the 62% who are worried about bird flu type viruses.
The EU proposal for legislation called REACH suggests that all chemicals used in industry must be registered, evaluated and approved and that the spread of potentially harmful chemicals be limited. CASCADE studies different aspects of endocrine systems, and argue that decisions on how a chemical is used must be based on scientific data.
"We believe that the EU Parliament must consider long-term effects of exposure to chemicals and protect the European population from involuntary exposure to potentially toxic chemicals", says Professor Jan-Ake Gustafsson, Karolinska Institutet, coordinator of CASCADE.
As a result of REACH, EU will be one of the first regions in the world to form a joint view on health aspects of chemical contaminants in food. This legislation will have profound effects on areas such as industry, food safety and environmental concern within and outside EU. The much debated REACH proposal will be up for a second reading in the Parliament European Council later this year.
"We call for open discussions on the implications of REACH, with consumer organisations and industry. As a network of top scientists in this field we feel it is our responsibility to provide a platform for such discussions", says Jan-Åke Gustafsson.
More information here.
###
For more information, please contact:
Cecilia Johansson, Communication/Dissemination Manager, CASCADE Network Office, Karolinska Institutet, phone +46 8 608 92 37, mobile: +46 702 544 657. email: c.johansson.cascade@biosci.ki.se
Jan-Ake Gustafsson, professor, coordinator, Inst. for Biosciences and Nutrition, Karolinska Institutet, phone +46-8-8585 837 46, jan-ake.gustafsson@mednut.ki.se
Katarina Sternudd, press officer, Karolinska Institutet, phone +46-8-524 838 95, email katarina.sternudd@ki.se
Contact: Cecilia Johansson
c.johansson.cascade@biosci.ki.se
Karolinska Institutet
Visit our conferences section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/40364.php>
APA
http://www.medicalnewstoday.com/releases/40364.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



